Xenon Pharmaceuticals Inc. ( XENE) - Key Metrics
XENE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.11 | -$0.96 | -$0.96 |
| 2026Q1 | $0 | -$1.17 | -$1.02 | -$1.02 |
| 2025Q4 | $0 | -$1.33 | -$1.03 | -$1.03 |
| 2025Q3 | $0 | -$1.15 | -$0.91 | -$0.91 |
| 2025Q2 | $0 | -$1.07 | -$0.81 | -$0.82 |
XENE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -13.59 |
| 2026Q1 | 0% | -12.43 |
| 2025Q4 | 0% | -8.55 |
| 2025Q3 | 0% | -8.73 |
| 2025Q2 | 0% | -7.31 |
XENE
Price: $37.33
52 week price:
Earnings Per Share: -4.63 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 730900
Ebitda: -8.5 millionMarket Capitalization: 5.8 billion